For the sake of discussion? Given Rem- L is already approved in Japan why wouldn't they be using it for ARDS? Or is there any chance they were and the reason they ran out? Smarter people than me would know the answer. I know there are plenty of other factors but Japan's death rate is very low.
Population Cases Cases Per Mil Deaths Per Case Per Pop 1 Aust 25,000,000 26,565 0.11% 797 3.00% 0.0032% 2 USA 331,000,000 6,460,000 1.95% 193000 2.99% 0.0583% 3 UK 68,000,000 361,677 0.53% 41614 11.51% 0.0612% 4 Japan 126,000,000 74,000 0.06% 1412 1.91% 0.0011%
For the sake of discussion? Given Rem- L is already approved in...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $3.515M | 3.240M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 22111 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 53749 | 15 |
View Market Depth
| Last trade - 13.41pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |